These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 23697916)

  • 1. Preparation, in vitro evaluation and statistical optimization of carvedilol-loaded solid lipid nanoparticles for lymphatic absorption via oral administration.
    Shah MK; Madan P; Lin S
    Pharm Dev Technol; 2014 Jun; 19(4):475-85. PubMed ID: 23697916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development, Optimization, and Evaluation of Carvedilol-Loaded Solid Lipid Nanoparticles for Intranasal Drug Delivery.
    Aboud HM; El Komy MH; Ali AA; El Menshawe SF; Abd Elbary A
    AAPS PharmSciTech; 2016 Dec; 17(6):1353-1365. PubMed ID: 26743643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and evaluation of polymer coated carvedilol loaded solid lipid nanoparticles to improve the oral bioavailability: a novel strategy to avoid intraduodenal administration.
    Venishetty VK; Chede R; Komuravelli R; Adepu L; Sistla R; Diwan PV
    Colloids Surf B Biointerfaces; 2012 Jun; 95():1-9. PubMed ID: 22463845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of poloxamer 188 on lymphatic uptake of carvedilol-loaded solid lipid nanoparticles for bioavailability enhancement.
    Sanjula B; Shah FM; Javed A; Alka A
    J Drug Target; 2009 Apr; 17(3):249-56. PubMed ID: 19255893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emodin loaded solid lipid nanoparticles: preparation, characterization and antitumor activity studies.
    Wang S; Chen T; Chen R; Hu Y; Chen M; Wang Y
    Int J Pharm; 2012 Jul; 430(1-2):238-46. PubMed ID: 22465546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curcumin-loaded solid lipid nanoparticles have prolonged in vitro antitumour activity, cellular uptake and improved in vivo bioavailability.
    Sun J; Bi C; Chan HM; Sun S; Zhang Q; Zheng Y
    Colloids Surf B Biointerfaces; 2013 Nov; 111():367-75. PubMed ID: 23856543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral solid compritol 888 ATO nanosuspension of simvastatin: optimization and biodistribution studies.
    Shah M; Chuttani K; Mishra AK; Pathak K
    Drug Dev Ind Pharm; 2011 May; 37(5):526-37. PubMed ID: 21128704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid-Based Gliclazide Nanoparticles for Treatment of Diabetes: Formulation, Pharmacokinetics, Pharmacodynamics and Subacute Toxicity Study.
    Nazief AM; Hassaan PS; Khalifa HM; Sokar MS; El-Kamel AH
    Int J Nanomedicine; 2020; 15():1129-1148. PubMed ID: 32110012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fabrication of solid lipid nanoparticles of lurasidone HCl for oral delivery: optimization,
    Patel MH; Mundada VP; Sawant KK
    Drug Dev Ind Pharm; 2019 Aug; 45(8):1242-1257. PubMed ID: 30880488
    [No Abstract]   [Full Text] [Related]  

  • 10. Fabrication of novel GMO/Eudragit E100 nanostructures for enhancing oral bioavailability of carvedilol.
    Patil SS; Roy K; Choudhary B; Mahadik KR
    Drug Dev Ind Pharm; 2016 Aug; 42(8):1300-7. PubMed ID: 26651381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solid lipid nanoparticles of diethylcarbamazine citrate for enhanced delivery to the lymphatics: in vitro and in vivo evaluation.
    Siram K; Chellan VR; Natarajan T; Krishnamoorthy B; Mohamed Ebrahim HR; Karanam V; Muthuswamy SS; Ranganathan HP
    Expert Opin Drug Deliv; 2014 Sep; 11(9):1351-65. PubMed ID: 24847779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Candesartan cilexetil loaded solid lipid nanoparticles for oral delivery: characterization, pharmacokinetic and pharmacodynamic evaluation.
    Dudhipala N; Veerabrahma K
    Drug Deliv; 2016; 23(2):395-404. PubMed ID: 24865287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solid lipid nanoparticles for transdermal delivery of avanafil: optimization, formulation, in-vitro and ex-vivo studies.
    Kurakula M; Ahmed OA; Fahmy UA; Ahmed TA
    J Liposome Res; 2016 Dec; 26(4):288-96. PubMed ID: 26784833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of process variables of zanamivir-loaded solid lipid nanoparticles and the prediction of their cellular transport in Caco-2 cell model.
    Shi LL; Cao Y; Zhu XY; Cui JH; Cao QR
    Int J Pharm; 2015 Jan; 478(1):60-69. PubMed ID: 25448568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of solid lipid nanoparticles (SLNs) of lopinavir using hot self nano-emulsification (SNE) technique.
    Negi JS; Chattopadhyay P; Sharma AK; Ram V
    Eur J Pharm Sci; 2013 Jan; 48(1-2):231-9. PubMed ID: 23153618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved anti-hyperlipidemic activity of Rosuvastatin Calcium via lipid nanoparticles: Pharmacokinetic and pharmacodynamic evaluation.
    Dudhipala N; Veerabrahma K
    Eur J Pharm Biopharm; 2017 Jan; 110():47-57. PubMed ID: 27810472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solid lipid nanoparticles (SLNs) to improve oral bioavailability of poorly soluble drugs.
    Hu L; Tang X; Cui F
    J Pharm Pharmacol; 2004 Dec; 56(12):1527-35. PubMed ID: 15563759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation design, preparation and physicochemical characterizations of solid lipid nanoparticles containing a hydrophobic drug: effects of process variables.
    Das S; Ng WK; Kanaujia P; Kim S; Tan RB
    Colloids Surf B Biointerfaces; 2011 Nov; 88(1):483-9. PubMed ID: 21831615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naringenin-loaded solid lipid nanoparticles: preparation, controlled delivery, cellular uptake, and pulmonary pharmacokinetics.
    Ji P; Yu T; Liu Y; Jiang J; Xu J; Zhao Y; Hao Y; Qiu Y; Zhao W; Wu C
    Drug Des Devel Ther; 2016; 10():911-25. PubMed ID: 27041995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solid lipid nanoparticles loaded with iron to overcome barriers for treatment of iron deficiency anemia.
    Hosny KM; Banjar ZM; Hariri AH; Hassan AH
    Drug Des Devel Ther; 2015; 9():313-20. PubMed ID: 25609917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.